RSS

Glial Cell Line Derived Neurotrophic Factor (GDNF)

Renishaw has built a device used in a clinical trial that allows the delivery of Glial Cell Line Derived Neurotrophic Factor (GDNF) with the hope of regenerating dying dopamine brain cells in people with Parkinson’s. Read more

Devices